The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway

Author: Smith Sherri   Hoyt Jennifer   Whitebread Nigel   Manna Joseph   Peluso Marisa   Faia Kerrie   Campbell Veronica   Tremblay Martin   Nair Somarajan   Grogan Michael   Castro Alfredo   Campbell Matthew   Ferguson Jeanne   Arsenault Brendan   Nevejans Jylle   Carter Bennett   Lee John   Dunbar Joi   McGovern Karen   Read Margaret   Adams Julian   Constan Alexander   Loewen Gordon   Sydor Jens   Palombella Vito   Soglia John  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.43, Iss.10, 2013-10, pp. : 875-885

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content